Showing results (641-650 of 654) with videos related to

Sort By:
Pageof 66
Blood|April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell TherapyKai Rejeski, Jaime Sanz, Teng Fei, et al.
The New England Journal of Medicine|November 19, 2004
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cellsSandeep S Dave, George Wright, Bruce Tan, et al.
Blood|January 5, 2026
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell LymphomaDanny Luan, Ori Ben Valid, Ofrat Beyar-Katz, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
JAMA Cardiology|April 15, 2026
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical TrialNeil J Craig, Krithika Loganath, Russell J Everett, et al.
Blood|July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Blood|September 28, 2019
The whole-genome landscape of Burkitt lymphoma subtypesRazvan I Panea, Cassandra L Love, Jennifer R Shingleton, et al.
JAMA|October 28, 2024
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical TrialKrithika Loganath, Neil J Craig, Russell J Everett, et al.
The New England Journal of Medicine|June 15, 2022
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care UnitFrançois Lamontagne, Marie-Hélène Masse, Julie Menard, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Pageof 66